Abdul Malik Sheikh

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Usefulness of Serum High-Density Lipoprotein Cholesterol Level as an Independent Predictor of One-Year Mortality After Percutaneous Coronary Interventions

Ziyad Ghazzal, Saurabh S. Dhawan, Abdul Malik Sheikh et al. · The American Journal of Cardiology · 2009 · 32 citations

Percutaneous Coronary Intervention, One-year Mortality, Cardiovascular Epidemiology +14

Modulation of ADAR mRNA expression in patients with congenital heart defects

Faizah Altaf, Cornelia Vesely, Abdul Malik Sheikh et al. · PLoS ONE · 2019 · 30 citations · Full text

Heart Failure, Genetics, Congenital Heart Anomaly +19

In-hospital outcomes and temporal trends of percutaneous coronary interventions for chronic total occlusion

Spyridon Kostantinis, Bahadir Simsek, Judit Karácsonyi et al. · EuroIntervention · 2022 · 30 citations · Full text

Percutaneous Coronary Intervention, In-hospital Outcomes, Cardiovascular Disease +11